Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
Cancer Genomics & Proteomics
|
September 20, 2007
Drug transporters as targets for cancer chemotherapy
Takeo Nakanishi
Drug Metabolism and Pharmacokinetics
|
December 22, 2011
Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs
Takeo Nakanishi, Ikumi Tamai
Current Opinion in Pharmacology
|
September 25, 2013
OATP transporter-mediated drug absorption and interaction
Ikumi Tamai, Takeo Nakanishi
Journal of Pharmaceutical Sciences
|
June 2, 2011
Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy
Takeo Nakanishi, Ikumi Tamai
Biopharmaceutics & Drug Disposition
|
August 27, 2014
Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers
Takeo Nakanishi, Ikumi Tamai
Current Drug Metabolism
|
December 4, 2015
Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Takeo Nakanishi, Ikumi Tamai
The AAPS Journal
|
December 6, 2017
Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins
Takeo Nakanishi, Ikumi Tamai
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2009
Impact of breast cancer resistance protein on cancer treatment outcomes
Douglas D Ross, Takeo Nakanishi
Chinese Journal of Cancer
|
November 22, 2011
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
Takeo Nakanishi, Douglas D Ross
Pharmacology & Therapeutics
|
January 19, 2021
Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action
Takeo Nakanishi, Yoshinobu Nakamura, Junji Umeno
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
Cancer Genomics & Proteomics
|
September 20, 2007
Drug transporters as targets for cancer chemotherapy
Takeo Nakanishi
Drug Metabolism and Pharmacokinetics
|
December 22, 2011
Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs
Takeo Nakanishi, Ikumi Tamai
Current Opinion in Pharmacology
|
September 25, 2013
OATP transporter-mediated drug absorption and interaction
Ikumi Tamai, Takeo Nakanishi
Journal of Pharmaceutical Sciences
|
June 2, 2011
Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy
Takeo Nakanishi, Ikumi Tamai
Biopharmaceutics & Drug Disposition
|
August 27, 2014
Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers
Takeo Nakanishi, Ikumi Tamai
Current Drug Metabolism
|
December 4, 2015
Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Takeo Nakanishi, Ikumi Tamai
The AAPS Journal
|
December 6, 2017
Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins
Takeo Nakanishi, Ikumi Tamai
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2009
Impact of breast cancer resistance protein on cancer treatment outcomes
Douglas D Ross, Takeo Nakanishi
Chinese Journal of Cancer
|
November 22, 2011
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
Takeo Nakanishi, Douglas D Ross
Pharmacology & Therapeutics
|
January 19, 2021
Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action
Takeo Nakanishi, Yoshinobu Nakamura, Junji Umeno
Page
of 14